Newron Pharmaceuticals SpA
SIX:NWRN

Watchlist Manager
Newron Pharmaceuticals SpA Logo
Newron Pharmaceuticals SpA
SIX:NWRN
Watchlist
Price: 7.61 CHF 2.15%
Market Cap: 145m CHF
Have any thoughts about
Newron Pharmaceuticals SpA?
Write Note

Newron Pharmaceuticals SpA
Accrued Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Newron Pharmaceuticals SpA
Accrued Liabilities Peer Comparison

Comparables:
REC
P
PRL
FCM
SHE

Competitive Accrued Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Accrued Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Newron Pharmaceuticals SpA
SIX:NWRN
Accrued Liabilities
€3.5m
CAGR 3-Years
2%
CAGR 5-Years
8%
CAGR 10-Years
N/A
Recordati Industria Chimica e Farmaceutica SpA
MIL:REC
Accrued Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
P
Pierrel SpA
MIL:PRL
Accrued Liabilities
€2.9m
CAGR 3-Years
8%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Friulchem SpA
MIL:FCM
Accrued Liabilities
€446.8k
CAGR 3-Years
3%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Shedir Pharma Srl Unipersonale
MIL:SHE
Accrued Liabilities
€656k
CAGR 3-Years
-14%
CAGR 5-Years
-27%
CAGR 10-Years
N/A

See Also

What is Newron Pharmaceuticals SpA's Accrued Liabilities?
Accrued Liabilities
3.5m EUR

Based on the financial report for Dec 31, 2023, Newron Pharmaceuticals SpA's Accrued Liabilities amounts to 3.5m EUR.

What is Newron Pharmaceuticals SpA's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 5Y
8%

Over the last year, the Accrued Liabilities growth was 61%. The average annual Accrued Liabilities growth rates for Newron Pharmaceuticals SpA have been 2% over the past three years , 8% over the past five years .

Back to Top